Published on 24 Apr 2024 on GuruFocus.com via Yahoo Finance

Thermo Fisher Scientific Inc (TMO) Q1 2024 Earnings: Adjusted EPS Outperforms Analyst Expectations

Revenue: Reported $10.34 billion for Q1 2024, a decrease of 3% year-over-year, falling short of estimates of $10.169 billion.Net Income: Achieved $1.328 billion, up 3% from $1.289 billion in Q1 2023, exceeding estimates of $1.824 billion.Earnings Per Share (EPS): GAAP diluted EPS was $3.46, up 4% from $3.32 year-over-year, while adjusted EPS rose to $5.11 from $5.03, surpassing the estimated EPS of $4.71.Operating Margin: GAAP operating margin improved to 16.1% from 14.6% in the previous year; adjusted operating margin also increased slightly to 22.0% from 21.8%.Dividend: Announced an 11% increase in the dividend, reflecting strong financial health and confidence in future earnings.Stock Repurchase: Actively returned value to shareholders with a significant $3.0 billion stock repurchase during the quarter.Full-Year Guidance: Raised full-year revenue guidance to $42.3 billion to $43.3 billion and adjusted EPS guidance to $21.14 to $22.02, indicating expected continued strong performance.

Warning! GuruFocus has detected 8 Warning Sign with TMO.